--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Glucose Buddy Diabetes Tracker" developer_entity: "Azumio Inc." bundle_id: "com.OneAppOneCause.GlucoseBuddy" app_store_id: "294754639" google_play_id: "com.skyhealth.glucosebuddyfree" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-04-26" report_date: "2026-08-17" last_verified: "2026-08-17T00:00:00.000Z" report_version: "5.442" total_reviews: 39132 overall_rating: 3.9 sentiment: "Frustrated" sentiment_score: 25 confidence: "high" confidence_score: 0.85 top_praise_theme: "Long-term users value the comprehensive tracking of glucose, medication, and weight for medical reporting" top_complaint_theme: "Persistent application crashes and loading failures following the latest update prevent users from accessing health data" review_sample_size: 509 total_review_count: 509 analyzed_review_count: 95 data_age_days: 89 momentum_velocity: "maintenance" intelligence_version: 6 nemesis: "mySugr - Diabetes Tracker Log" competitor_count: 7 tags: ["medical", "subscription", "frustrated sentiment", "mobile app", "app review", "app analysis", "individuals", "managing", "diabetes"] canonical_url: "https://marlvel.ai/apps/com-oneapponecause-glucosebuddy" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Glucose Buddy Diabetes Tracker Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 3.87 · Sentiment Frustrated - **Recent focus**: Persistent application crashes and loading failures following the latest update prevent users from accessing health data (top complaint) · Long-term users value the comprehensive tracking of glucose, medication, and weight for medical reporting (top praise) > **TL;DR:** Glucose Buddy Diabetes Tracker is a medical app by Azumio Inc., rated 3.87/5 by 39.1K users, with Frustrated user sentiment (25/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Glucose Buddy Diabetes Tracker faces Frustrated user sentiment (3.87/5 from 39.1K reviews), with users reporting persistent application crashes and loading failures following the latest update prevent users from accessing health data as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 3.87/5 (39.1K reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Azumio Inc. | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | High (0.85/1.0) | | **Data Age** | 89d | ## Metadata & Market Performance - **Publisher:** Azumio Inc. - **Category:** Medical - **Target Audience:** Individuals managing diabetes who require consistent blood sugar tracking, carb logging, and professional health guidance. - **Platforms:** iOS & Android - **Version Reviewed:** 5.442 - **Report Date:** 2026-08-17 - **Signal Count:** 509 reviews analyzed - **Confidence:** High (0.85/1.0) - **App Store ID (iOS):** 294754639 - **Bundle ID:** com.OneAppOneCause.GlucoseBuddy - **Google Play ID:** com.skyhealth.glucosebuddyfree - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-17 - **Short Description:** Track blood glucose, A1C, carbs, medication, exercise, and more all in one app! ## Executive Snapshot **What it is:** Glucose Buddy Diabetes Tracker is a medical logging app for diabetes management, providing glucose, medication, and A1C tracking on iOS and Android. **Why users hire it:** The app removes the cognitive friction of manual health logging by centralizing glucose, carb, and medication data into a single, shareable report for physician review. ## App DNA (Features & Intent) - **[Standard] Glucose Tracking:** Logs blood glucose levels with support for mg/dL and mmol/L units * *User Intent:* Users want visibility into their own performance and progress. - **[Differentiator] Automatic A1C Calculator:** Calculates long-term A1C trends based on logged glucose data - **[Differentiator] Hardware Integration:** Syncs data from Dexcom and Agamatrix Jazz Wireless 2 meters * *User Intent:* Users expect seamless access across multiple devices. ## Market Position {#market-position} Glucose Buddy Diabetes Tracker sits #55 Grossing in the US Medical category, yet the 113-day gap since the last store update signals a shift toward maintenance-mode. The grossing rank lagging behind the app's 15-year legacy suggests that monetization pressure is currently outpacing feature value delivery. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free tier with ads, Premium subscription starting at $19/month - **Analysis:** Freemium model gates advanced analytics and ad-free experience behind a monthly subscription, with additional revenue from hardware-service bundles. ## 🔴 User Sentiment (High Confidence: 95 of 509 reviews analyzed) {#user-sentiment} - **Overall Rating:** 3.87/5 - **Platform Split:** iOS 4.8/5 (24.6K ratings) | Android 2.3/5 (14.6K ratings) - **Overall Sentiment:** Frustrated ### Top Praises - **Long-term users value the comprehensive tracking of glucose, medication, and weight for medical reporting** ### Top Complaints (Impact Areas) - **Persistent application crashes and loading failures following the latest update prevent users from accessing health data** ## SWOT Analysis {#swot} **Core Strengths:** - 15-year legacy builds trust for chronic condition management - All-in-one dashboard reduces cognitive load for multi-metric tracking **Growth Levers:** - Implement offline-first data persistence to capture users in low-connectivity environments ## Recent Changes (v5 → v6) {#recent-changes} Launch-time stability failures have become the primary driver of user churn, shifting the app's sentiment from legacy trust to active dissatisfaction. This technical crisis is compounded by new reports of unresponsive billing support, further weakening the app's competitive standing. **Overall trend**: Declining **Compared at**: 2026-08-17 ### High-impact changes - **[Declined] Escalation of Stability Issues** (sentiment) - **[Added] Billing and Support Complaints** (sentiment) ### Medium-impact changes - **[] Grossing Rank Decline** (positioning) - **[Removed] Feature Gap Refinement** (features) ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Glucose Buddy Diabetes Tracker vs mySugr - Diabetes Tracker Log - **[mySugr - Diabetes Tracker Log](https://marlvel.ai/apps/com-mysugr-companion-mysugr)** by mySugr GmbH: With over 134,000 reviews and a high-velocity release cadence, mySugr is the dominant direct competitor in the diabetes logging space. - **Key differences:** - Gamified logging experience provides immediate positive reinforcement for consistent blood glucose data entry - Deep integration with various continuous glucose monitors (CGM) automates data flow for power users - High-frequency release cycle of 12 updates in six months ensures rapid feature iteration and stability ### Contenders (Strong Challengers) - **[Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe)** by MediSafe Inc.: A strong contender that captures the medication adherence segment of the diabetes management workflow. - Specialized medication reminder engine with family caregiver alerts outperforms generic logging features - Drug-to-drug interaction checking provides a safety layer that standard diabetes trackers lack - **[Libre by Abbott](https://marlvel.ai/apps/com-abbott-adc-freestyle-libre-us)** by Abbott Labs: Dominates the CGM-specific niche, serving as a critical utility for users requiring real-time glucose monitoring. - Real-time glucose streaming capabilities eliminate the need for manual logging of blood sugar levels - Hardware-integrated alerts provide immediate notification of dangerous glucose fluctuations for patient safety - **[OneTouch Reveal® app](https://marlvel.ai/apps/com-lifescan-reveal)** by LifeScan, Inc.: A major contender backed by a medical device manufacturer, focusing on seamless hardware-to-app data synchronization. - Direct hardware ecosystem lock-in through proprietary blood glucose meter connectivity and data syncing - Clinical-grade reporting features designed specifically for sharing accurate data with healthcare providers ### Peers (What They Do Better) - **[Kardia](https://marlvel.ai/apps/com-alivecor-professional-aliveecg)** by AliveCor, Inc.: Adjacent chronic condition monitoring, focusing on cardiovascular health often comorbid with diabetes. - Medical-grade ECG analysis capabilities provide specialized diagnostic value beyond simple glucose tracking - Hardware-software synergy with portable ECG devices creates a distinct clinical diagnostic workflow - **[GoodRx: Prescription Savings](https://marlvel.ai/apps/com-goodrx-iphone)** by GoodRx: Adjacent medical utility that captures the financial pain point of diabetes management. - Aggressive price comparison engine for prescriptions creates a high-utility financial moat for patients - Massive user base and brand recognition as the primary tool for reducing healthcare costs ### New Kids on the Block (What's Innovative) - **[Blood Pressure Tracker •](https://marlvel.ai/apps/com-adappt-bp)** by App Sub 1 LLC: Recent updates and high activity suggest an emerging focus on comorbid condition tracking. - Minimalist, single-purpose interface design reduces friction for elderly users tracking blood pressure - Rapid release cadence indicates a focus on quick feature deployment to capture niche users ## What's New - **Latest (v5.442, 3 weeks ago):** UI redesign, performance upgrades, and bug fixes. ## App Momentum (Maintenance) {#momentum} - Ships bug fixes at ~4-month cadence. - Latest release introduced widespread launch failures. > **Cadence:** 3 total versions · 0 majors in last 6 months · 22 days since last update · 325 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Glucose Buddy Diabetes Tracker is a medical app. With a 3.87/5 rating from 39.1K reviews, it faces significant user friction. > **Bottom Line:** Restoring core stability is the only path to retaining the legacy user base, as the current launch-time crashes are actively destroying the app's primary utility. Without a fix, the churn rate will continue to outpace new user acquisition. **Best for:** Individuals managing diabetes who require consistent blood sugar tracking, carb logging, and professional health guidance. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Rebuild launch sequence because launch-time crashes are the #1 churn driver → restore daily active usage ### Feature Gaps vs Competitors - Real-time CGM streaming (available in Libre by Abbott but absent here) ### Outlook: Declining The diabetes management market is consolidating around automated, CGM-integrated solutions that remove the manual logging friction Glucose Buddy requires. The current maintenance-mode cadence leaves the app exposed to churn, and the latest stability regressions will likely accelerate the loss of the legacy user base into Q3. - 🔴 The latest update introduced widespread launch failures, which erodes the daily active habit and compounds the rating drag already visible on Android. - 🔴 Maintenance-mode release cadence leaves the app exposed to live-ops rivals like mySugr, which iterate on features every two weeks. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 3.87/5 | | Total Reviews | 39.1K | | Sentiment | Frustrated (25/100) | | Confidence | High | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Glucose Buddy Diabetes Tracker** (this app) | 3.87/5 | Frustrated | Azumio Inc. | | [Libre by Abbott](https://marlvel.ai/apps/com-abbott-adc-freestyle-libre-us) | 4.6/5 | Mixed | Abbott Labs | | [GoodRx: Prescription Savings](https://marlvel.ai/apps/com-goodrx-iphone) | 4.8/5 | Thrilled | GoodRx | | [Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe) | 4.7/5 | n/a | MediSafe Inc. | | [Kardia](https://marlvel.ai/apps/com-alivecor-professional-aliveecg) | 4.8/5 | N/A | AliveCor, Inc. | | [OneTouch Reveal® app](https://marlvel.ai/apps/com-lifescan-reveal) | 4.8/5 | N/A | LifeScan, Inc. | ## Company Profile - **Developer:** Azumio Inc. - **Website:** [https://www.glucosebuddy.com](https://www.glucosebuddy.com) ## Data Sources & Links - **App Store ID:** 294754639 - **Google Play ID:** com.skyhealth.glucosebuddyfree - **Dev Site:** [Official Website](https://www.glucosebuddy.com) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*Libre by Abbott*](https://marlvel.ai/apps/com-abbott-adc-freestyle-libre-us) (Abbott Labs) · 4.6/5 Rating - [*GoodRx: Prescription Savings*](https://marlvel.ai/apps/com-goodrx-iphone) (GoodRx) · 4.8/5 Rating | Excellent Sentiment - [*Medisafe Medication Management*](https://marlvel.ai/apps/com-medisafe-medisafe) (MediSafe Inc.) · 4.7/5 Rating - [*Kardia*](https://marlvel.ai/apps/com-alivecor-professional-aliveecg) (AliveCor, Inc.) · 4.8/5 Rating - [*OneTouch Reveal® app*](https://marlvel.ai/apps/com-lifescan-reveal) (LifeScan, Inc.) · 4.8/5 Rating - [*Blood Pressure Tracker •*](https://marlvel.ai/apps/com-adappt-bp) (App Sub 1 LLC) · 4.7/5 Rating - [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/apps/com-mysugr-companion-mysugr) (mySugr GmbH) · 4.7/5 Rating - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.85/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 509 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 89 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-oneapponecause-glucosebuddy) Data licensed for AI Agent attribution under CC-BY-NC 4.0.